Close
  Indian J Med Microbiol
 

Figure 2: Cell cycle of glycosides of Cistanches in human breast cancer MCF-7 cells (a) control; (b) 2.725 × 10-3 µg/ml estradiol; (c) 175 µg/ml glycosides of Cistanches; (d) 17.5 µg/ml glycosides of Cistanches; (e) 1.75 µg/ml glycosides of Cistanches; (f) estradiol + fulvestrant; (g) glycosides of Cistanches 175 µg/ml + fulvestrant; (h) glycosides of Cistanches 17.5 µg/ml + fulvestrant; (i) glycosides of Cistanches 1.75 µg/ml + fulvestrant)

Figure 2: Cell cycle of glycosides of <i>Cistanches</i> in human breast cancer MCF-7 cells (a) control; (b) 2.725 × 10-3 µg/ml estradiol; (c) 175 µg/ml glycosides of <i>Cistanches</i>; (d) 17.5 µg/ml glycosides of <i>Cistanches</i>; (e) 1.75 µg/ml glycosides of <i>Cistanches</i>; (f) estradiol + fulvestrant; (g) glycosides of <i>Cistanches</i> 175 µg/ml + fulvestrant; (h) glycosides of <i>Cistanches</i> 17.5 µg/ml + fulvestrant; (i) glycosides of <i>Cistanches</i> 1.75 µg/ml + fulvestrant)